"Mutation" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations.
| Descriptor ID |
D009154
|
| MeSH Number(s) |
G05.365.590
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Mutation".
Below are MeSH descriptors whose meaning is more specific than "Mutation".
This graph shows the total number of publications written about "Mutation" by people in this website by year, and whether "Mutation" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 12 | 31 | 43 |
| 1995 | 15 | 26 | 41 |
| 1996 | 24 | 22 | 46 |
| 1997 | 26 | 16 | 42 |
| 1998 | 23 | 37 | 60 |
| 1999 | 14 | 34 | 48 |
| 2000 | 27 | 41 | 68 |
| 2001 | 15 | 48 | 63 |
| 2002 | 21 | 49 | 70 |
| 2003 | 20 | 76 | 96 |
| 2004 | 19 | 61 | 80 |
| 2005 | 23 | 80 | 103 |
| 2006 | 25 | 72 | 97 |
| 2007 | 27 | 56 | 83 |
| 2008 | 25 | 68 | 93 |
| 2009 | 25 | 69 | 94 |
| 2010 | 34 | 66 | 100 |
| 2011 | 35 | 83 | 118 |
| 2012 | 45 | 69 | 114 |
| 2013 | 42 | 68 | 110 |
| 2014 | 44 | 80 | 124 |
| 2015 | 47 | 88 | 135 |
| 2016 | 39 | 93 | 132 |
| 2017 | 34 | 77 | 111 |
| 2018 | 42 | 105 | 147 |
| 2019 | 48 | 68 | 116 |
| 2020 | 26 | 88 | 114 |
| 2021 | 25 | 84 | 109 |
| 2022 | 8 | 80 | 88 |
| 2023 | 2 | 83 | 85 |
| 2024 | 24 | 51 | 75 |
To return to the timeline,
click here.
Below are the most recent publications written about "Mutation" by people in Profiles.
-
Indeterminate DC histiocytosis is distinct from LCH and often associated with other hematopoietic neoplasms. Blood Adv. 2024 Nov 26; 8(22):5796-5805.
-
Risk prediction for clonal cytopenia: multicenter real-world evidence. Blood. 2024 Nov 07; 144(19):2033-2044.
-
Prognostic impact of 'multi-hit' versus 'single-hit' TP53 alteration in patients with acute myeloid leukemia: results from the Consortium on Myeloid Malignancies and Neoplastic Diseases. Haematologica. 2024 11 01; 109(11):3533-3542.
-
Beat-AML 2024 ELN-refined risk stratification for older adults with newly diagnosed AML given lower-intensity therapy. Blood Adv. 2024 10 22; 8(20):5297-5305.
-
Low PD-L1 expression, MAP2K2 alterations, and enriched HPV gene signatures characterize brain metastases in head and neck squamous cell carcinoma. J Transl Med. 2024 Oct 22; 22(1):960.
-
Post-transcriptional methylation of mitochondrial-tRNA differentially contributes to mitochondrial pathology. Nat Commun. 2024 Oct 18; 15(1):9008.
-
Palbociclib in Patients With Head and Neck Cancer and Other Tumors With CDKN2A Alterations: Results From the Targeted Agent and Profiling Utilization Registry Study. JCO Precis Oncol. 2024 Oct; 8:e2400477.
-
Medullary Thyroid Cancer: Single Institute Experience Over 3 Decades and Risk Factors for Recurrence. J Clin Endocrinol Metab. 2024 Oct 15; 109(11):2729-2734.
-
CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors. Nature. 2024 Nov; 635(8038):462-471.
-
MEN1/DAXX/ATRX mutations enhance progression-free survival in gastroenteropancreatic neuroendocrine tumors treated with peptide receptor radionuclide therapy. Endocr Relat Cancer. 2024 Nov 01; 31(11).